Study of ZL-65 tablet in healthy adults
This trial tests a new medicine called ZL-65, which may help treat certain conditions by reducing inflammation. It is a first-in-human study to see if the drug is safe and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your weight is at least 50 kg (about 110 lbs) for men or 45 kg (about 99 lbs) for women, and your body mass index is between 19 and 28.
- You are in good health overall with no major medical conditions.
- You are not allergic to this drug or its ingredients, and you have no serious allergies.
- If you are a woman, you are not pregnant or breastfeeding, and you agree to use effective contraception during the study.
- You agree to avoid caffeine, grapefruit, and alcohol before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new medicine called ZL-1503 in healthy volunteers to see how the body processes it and if it's safe. You may be able to join if you are in good health and meet certain age, weight, and lifestyle requirements.
This study is testing a new medicine called ZE66-0205 for the first time in people. It is looking at healthy volunteers to see how the drug is processed by the body and if it is safe.
This study tests a new medicine called ZP9830 to see if it is safe for people and how it works in the body. Healthy volunteers aged 18 to 45 can join.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial tests a new oral medication (GZC8072) in two groups: healthy people given a single dose, and people who are overweight or obese given multiple doses. The study aims to see if the drug is safe and how the body handles it, and may help with weight management.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
Hear when a new Healthy Participants Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.